Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection

被引：0

作者：

Diri, E

Lipsky, PE

Berggren, RE

机构：

[1] Univ Texas, SW Med Ctr, Dept Internal Med, Div Infect Dis, Dallas, TX 75390 USA

[2] Univ Texas, SW Med Ctr, Dept Internal Med, Div Rheumat Dis, Dallas, TX 75390 USA

[3] NIAMSD, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2000年 / 27卷 / 11期

关键词：

autoimmunity; lupus; human immunodeficiency virus; immune reconstitution disease; antiretroviral therapy;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systemic lupus erythematosus (SLE) may be influenced by human immunodeficiency virus type-1 (HIV) infection. It has been suggested that the immunosuppression resulting from HIV infection can prevent the emergence of SLE. There appear to be fewer cases of SLE in the HIV infected population than would be predicted, based on the overall incidence of SLE. We describe a person with HIV infection who developed SLE after the initiation of highly active antiretroviral therapy.

引用

页码：2711 / 2714

页数：4

共 50 条

[1] Reactivation of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for acquired immunodeficiency syndrome
Drake, WP
Byrd, VM
Olsen, NJ
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2003, 9 (03) : 176 - 180
[2] Systemic Lupus Erythematosus Onset Seven Years After Initiation of Highly Active Antiretroviral Therapy in a Patient With Human Immunodeficiency Virus: Literature Review and Update on Disease Mechanism of This Unusual Presentation
Modjinou, Dodji V.
Osman, Jamie L.
Haberman, Rebecca H.
Izmirly, Peter M.
Belmont, H. Michael
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (06) : 338 - 340
[3] Human immunodeficiency virus infection in systemic lupus erythematosus
Fox, RA
Isenberg, DA
[J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (06): : 1168 - 1172
[4] Immunological Response of Human Immunodeficiency Virus Positive Patients after Initiation of Highly Active Antiretroviral Therapy
Reddy, K. B. Yadavendra
Visalakshi, B.
Kirankumar, P.
[J]. INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2015, 3 (07) : 117 - 120
[5] Human immunodeficiency virus infection in patients with systemic lupus erythematosus
Ntumba, H. N.
Nzuzi, Mvudi A.
Tikly, M.
[J]. CLINICAL RHEUMATOLOGY, 2013, 32 : S131 - S132
[6] Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy
Awodu, Omolade A.
Olayemi, Edeghonghon E.
Bazuaye, Godwin N.
Onunu, Abel N.
[J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (01) : 47 - 49
[7] Ophthalmic Manifestations of Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy
Sorenson, Rebecca L.
Jeng, Bennie H.
[J]. ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (12) : 1621 - 1623
[8] Systemic lupus erythematosus in two adults with human immunodeficiency virus infection
Contreras, G
Green, DF
Pardo, V
Schultz, DR
Bourgoignie, JJ
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (02) : 292 - 295
[9] THE IMPACT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Tikly, M.
Ntumba, M. H. Ngandu
Mvudi, A. N.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S60 - S60
[10] Highly active antiretroviral therapy and human immunodeficiency virus encephalitis
Cook, JE
Dasgupta, S
Middaugh, LD
Terry, EC
Gorry, PR
Wesselingh, SL
Tyor, WR
[J]. ANNALS OF NEUROLOGY, 2005, 57 (06) : 795 - 803

← 1 2 3 4 5 →